Multidomain Outcomes of a Digital Self-Management Program in Rural Adults With Chronic Conditions: Single-Arm Prospective Interventional Study
JMIR mHealth and uHealth · 2026-10-30 · 14 · e95283-e95283
DOI: 10.2196/95283 ↗Abstrakt
Abstract Background Chronic disease and comorbid mental health problems disproportionately affect rural and underserved populations. Digital self-management programs are potentially scalable, but evaluations often focus on narrow outcomes. Objective This study examined 12-month longitudinal changes in psychological and multidomain outcomes among Pictou County Patient Empowerment Program participants and explored co-occurring changes and psychological moderators. Methods This single-arm prospective interventional study enrolled 182 community-dwelling adults with ≥1 chronic condition in Pictou County, Nova Scotia, between October 2023 and August 2025 through community-based outreach. Median age was 60 (IQR 51‐68) years, 155 of 182 (85.2%) participants were women, and the median number of chronic conditions was 3 (IQR 1‐3). The initial 6-month digital intervention delivered brief daily modules targeting physical activity, nutrition, stress regulation, sleep, habit formation, and social connection, followed by a 6-month lower-intensity maintenance period during which monthly group videoconference sessions continued to be offered. Outcomes were assessed at baseline, 6 months, and 12 months. Primary outcomes were illness perceptions (Brief Illness Perception Questionnaire), perceived stress (10-item Perceived Stress Scale [PSS-10]), disease-related worry (10-item Questionnaire on Distress in Cancer Patients), life satisfaction (Satisfaction With Life Scale), and mental well-being (World Health Organization-Five Well-Being Index [WHO-5]). Secondary outcomes assessed the physical, behavioral, and psychosocial domains. Generalized estimating equations estimated population-averaged longitudinal changes, adjusted for age, sex, relationship status, comorbidity burden, and baseline depression or anxiety medication use. Exploratory models examined co-occurring changes and moderation. Tests were 2-sided with α =.05. Results Across outcomes and follow-up assessments, completion ranged from 58.2% (95% CI 51.0%-65.2%; 106/182) to 65.4% (95% CI 58.2%‐71.9%; 119/182). At 12 months, illness perceptions decreased (β=−7.3, 95% CI −9.7 to −4.9), perceived stress decreased (β=−2.4, 95% CI −3.5 to −1.3), disease-related worry decreased (β=−6.3, 95% CI −7.8 to −4.7), life satisfaction increased (β=2.5, 95% CI 1.4‐3.5), and mental well-being increased (β=10.4, 95% CI 7.2‐13.5; all P
EUVIMED